The Grand Round concerns a 24-year-old man from Zimbabwe who was studying and living in Poland. The patient had been complaining of abdominal pain, fatigue, alternating diarrhoea and constipation, and presence of blood in his stool for 3 years. The pat...
The Grand Round concerns a 24-year-old man from Zimbabwe who was studying and living in Poland. The patient had been complaining of abdominal pain, fatigue, alternating diarrhoea and constipation, and presence of blood in his stool for 3 years. The pat...
Maranda B, Labbé SM, Lurquin M, et al. Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial. Lancet Infect Dis 2023; published online Aug 21. https://doi.o...
Maranda B, Labbé SM, Lurquin M, et al. Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial. Lancet Infect Dis 2023; published online Aug 21. https://doi.o...
A 59-year-old treatment-naive patient with advanced HIV infection presented with a severe and protracted course of mpox (formerly known as monkeypox) that did not respond to the current mpox treatment options. The patient worsened clinically, and devel...
A 59-year-old treatment-naive patient with advanced HIV infection presented with a severe and protracted course of mpox (formerly known as monkeypox) that did not respond to the current mpox treatment options. The patient worsened clinically, and devel...
Next-generation sequencing (NGS) of genomic data has established its fundamental value in public health surveillance, research and development, and precision medicine. In Africa, severe shortages of competent experts in genomics and bioinformatics, few...
Next-generation sequencing (NGS) of genomic data has established its fundamental value in public health surveillance, research and development, and precision medicine. In Africa, severe shortages of competent experts in genomics and bioinformatics, few...
Both molnupiravir and ritonavir-boosted nirmatrelvir accelerate oropharyngeal SARS-CoV-2 viral clearance in patients with COVID-19, but the antiviral effect of ritonavir-boosted nirmatrelvir was substantially greater. Measurement of oropharyngeal viral...
Both molnupiravir and ritonavir-boosted nirmatrelvir accelerate oropharyngeal SARS-CoV-2 viral clearance in patients with COVID-19, but the antiviral effect of ritonavir-boosted nirmatrelvir was substantially greater. Measurement of oropharyngeal viral...
The trial reported by William Schilling and colleagues1 in The Lancet Infectious Diseases adds crucial data to guide treatment decisions between clinicians and patients at this stage of the COVID-19 pandemic. This appears to be the first published rand...
The trial reported by William Schilling and colleagues1 in The Lancet Infectious Diseases adds crucial data to guide treatment decisions between clinicians and patients at this stage of the COVID-19 pandemic. This appears to be the first published rand...
Dengue poses an ongoing public health threat in most tropical and subtropical regions, and is poised to increase further in incidence and geographic distribution.1 The Laboratory of Infectious Diseases at the National Institutes of Health (NIH)–Nationa...
Dengue poses an ongoing public health threat in most tropical and subtropical regions, and is poised to increase further in incidence and geographic distribution.1 The Laboratory of Infectious Diseases at the National Institutes of Health (NIH)–Nationa...
After a prolonged period of near-complete global dominance of the recombinant XBB family of SARS-CoV-2 lineages, a substantially mutated sublineage of BA.2 has recently emerged. Designated BA.2.86,1 the geographic origin of this sublineage is currently...
After a prolonged period of near-complete global dominance of the recombinant XBB family of SARS-CoV-2 lineages, a substantially mutated sublineage of BA.2 has recently emerged. Designated BA.2.86,1 the geographic origin of this sublineage is currently...
